Clinical Practice Guidelines
The United States Multi-Society Task Force (MSTF) on Colorectal Cancer Screening updated its recommendations, confirming that screening in people at average risk should begin at age 50 years. The update also includes a ranking of current screening modalities.
A report on adherence to NCCN Guidelines found that, contrary to guideline recommendations, many asymptomatic patients with stage I/II breast cancer undergo chest CT for pulmonary nodules.
NCCN released its newest Clinical Practice Guidelines in Oncology. These guidelines will assist with preventive, diagnostic, and treatment decisions for patients with myelofibrosis, as well as the other myeloproliferative neoplasms, essential thrombocythemia and PV.
Dermatologist assessment of screening practices addresses the lack of a national consensus on screening guidelines for melanoma.
ASCO and Cancer Care Ontario issued a joint update to guidelines for brachytherapy for prostate cancer that take into account new evidence.
Zoledronic acid and clodranate are the recommended bisphosphonates for the adjuvant treatment of postmenopausal patients with breast cancer.
ASCO endorses ACS head and neck survivorship care guideline, which supports health promotion, especially regarding tobacco cessation and dental care.
Solid organ transplant recipients (SOTRs) are 3 times more likely to develop cancer; however, clinical practice guidelines for cancer screening in this population do not reflect this increased risk.
Collaboration between physicians and industry is vital in developing effective cancer treatments; however, a new study reveals the potential for undue influence among guideline authors may be significant.
ASCO has laid out a game plan to set the stage for incorporating new therapies and approaches into clinical guidelines as quickly and accurately as possible.
Most US cancer prevention and screening recommendations do not provide adequate information for making informed care decisions.
ASCO has published its first clinical practice guideline on invasive cervical cancer, and the guidelines are the first to offer treatment recommendations tailored to resource availability.
Surgery for early stage small cell lung cancer (SCLC) is rarely used. However, results from a population-based database has shown surgery with adjuvant chemotherapy with or without radiation for node-negative SCLC was associated with better survival compared with concurrent chemoradiation, according to a presentation at the 2016 ASCO Annual Meeting.
The 2016 consensus statement from the International Association for the Study of Lung Cancer (IASLC) describes how to best manage EGFR-mutation-positive NSCLC.
Most cancer prevention and screening recommendation statements fail to quantify benefits and harms or present them in an uneven manner, which might limit clinicians and patients in making informed decisions.
As the American College of Surgeons' Commision on Cancer milestones approach, ASTRO publishes a template to ensure consistent, comprehensive survivorship care plans can be developed for cancer survivors whose treatment involved radiotherapy.
A new clinical practice guideline on the appropriate use of tests for breast tumor biomarkers was issued by ASCO.
American Cancer Society and American Society of Clinical Oncology publish their breast cancer survivorship care guideline, providing care guidance for the estimated 3.1 million female adult survivors of breast cancer in the United States.
New, evidence-based recommendations from the American Thyroid Association will help guide the management of thyroid nodules. The new guidelines also focus on diagnosis and management of DTC, an increasingly prevalent form of cancer.
The American Cancer Society (ACS) has released its second in a series of cancer survivorship care guidelines.
New templates from the American Society of Clinical Oncology (ASCO) will augment successful cancer survivorship care planning. But a stronger effort toward implementation is still needed.
The American College of Physicians (ACP) has released updated guidance for screening average-risk adults without symptoms for breast, cervical, colorectal, ovarian, and prostate cancer.
A majority of surgeon continue to recommend annual breast cancer screening for women in their forties, despite a 2009 US Preventive Services Task Force (USPSTF) recommendation that recommends otherwise.
The NCCN Clinical Practice Guidelines in Oncology for Smoking Cessation can help you plan a successful quit program for your patients who smoke.
Treatment guidelines for pediatric Hodgkin lymphoma issued by the International Lymphoma Radiation Oncology Group (ILROG)April 01, 2015
The International Lymphoma Radiation Oncology Group (ILROG) has issued a guideline outlining use of 3-D computed tomography (CT)-based radiation therapy planning.
A review of top clinical guidelines for rectal cancer shows a variety of treatment recommendations.
Clinicians should discuss the prophylactic use of tamoxifen as well as two other agents with women 35 years and older and at increased risk of ER-positive breast cancer, per ASCO recommendations.
Results for almost half of U.S. cancer drug trials are still not available three years after study completion.
The Society of Thoracic Surgeons (STS) has released new clinical-practice guidelines that feature evidence-based recommendations to help clinicians diagnose and stage esophageal cancer.
New guidelines have been developed to treat recently diagnosed multiple myeloma in patients who are not participating in clinical trials.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|